The Impact of the COVID-19 Pandemic on the Uptake of the Influenza Vaccine: UK-Wide Observational Study

In the face of the COVID-19 pandemic, the UK National Health Service (NHS) extended eligibility for influenza vaccination this season to approximately 32.4 million people (48.8% of the population). Knowing the intended uptake of the vaccine will inform supply and public health messaging to maximize vaccination.


View the study also here.